Oaktree Acquisition Corp. III Life Sciences (OACC) Cash from Operations (2025 - 2026)

Oaktree Acquisition Corp. III Life Sciences (OACC) reported Cash from Operations of 158035.0 for Q1 2026, down 109.15% on a YoY basis from 1727366.21 in Q1 2025, and down 9.84% quarter-over-quarter from 143876.0 in Q4 2025.

Oaktree Acquisition Corp. III Life Sciences (OACC) Cash from Operations (2025 - 2026) Analysis & Trends

Oaktree Acquisition Corp. III Life Sciences has reported Cash from Operations for 2 years, with the latest figure at 158035.0 in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Operations fell 109.15% year-over-year to 158035.0; the trailing twelve-month figure through Mar 2026 stood at 504553.0 (changed N/A YoY), and the FY2025 full-year result was 422079.0, down 370.61% from the prior year.
  • Cash from Operations for Q1 2026 stood at 158035.0, down from 143876.0 in the prior quarter.
  • The five-year high for Cash from Operations was 56518.0 in Q3 2025, with the low at 158035.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn - -121,028.00
2 Berto Acquisition 312.46 Mn 312.46 Mn - -119,667.00
3 Centurion Acquisition 311.65 Mn 311.65 Mn - -72,157.00
4 GP-Act III Acquisition 311.36 Mn 311.36 Mn - 10,832.00
5 Churchill Capital Corp IX 310.79 Mn 310.79 Mn - -334,671.00
6 WEN Acquisition 309.15 Mn 309.15 Mn - -195,797.00
7 Bold Eagle Acquisition 275.54 Mn 275.54 Mn - -171,240.00
8 Soulpower Acquisition 264.91 Mn 264.91 Mn - -1.42 Mn
9 BTC Development 262.16 Mn 262.16 Mn - -537,350.00
10 Oaktree Acquisition Corp. III Life Sciences 57.34 Mn 57.34 Mn - -158,035.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -158,035.00
Mar 31, 2026 -158,035.00
Dec 31, 2025 -143,876.00
Dec 31, 2025 -143,876.00
Sep 30, 2025 -56,518.00
Sep 30, 2025 -56,518.00
Jun 30, 2025 -146,124.00
Jun 30, 2025 -146,124.00
Mar 31, 2025 -75,561.00
Mar 31, 2025 -75,561.00